TRICHECO: Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists (clinicaltrials.gov) - Apr 24, 2026 - P3 | N=554 | Not yet recruiting | Sponsor: Chiesi Farmaceutici S.p.A.
New P3 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
|